Rhizopus (Rhizopus oryzae)

**Product type:** Non-Standardized Allergenic

**Active ingredient:** RHIZOPUS ARRHIZUS

**Strength:** .1 g/mL

**Dosage form:** Injection

**Route:** Cutaneous; Intradermal; Subcutaneous

**Labeler:** Allermed Laboratories, Inc.

**Marketing category:** BLA (BLA102211)

**Pharmacologic class:** Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]